Zantac / Ranitidine (NDMA Cancer) Attorney in Charlotte, North Carolina

Zantac Litigation in Charlotte

Charlotte's Mecklenburg County Superior Court handles complex civil cases for the Carolinas' largest metro area. North Carolina applies Daubert under N.C. R. Evid. 702 but has a favorable 3-year SOL that gives claimants with 2023 or later diagnoses active filing windows. Charlotte-area Zantac claimants should consult national plaintiffs' counsel about the Delaware Superior Court as a primary venue given Judge Medinilla's favorable docket management. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Resources for Charlotte Zantac Claimants

Charlotte-area Zantac claimants should gather pharmacy records from CVS, Walgreens, Harris Teeter, and Food Lion pharmacies. Levine Cancer Institute at Atrium Health and Novant Health records documenting bladder, esophageal, stomach, or colorectal cancer are critical evidence. North Carolina's 3-year SOL is more favorable than most states and gives claimants with 2023 diagnoses an active filing window.